{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:53:37Z","timestamp":1760576017169,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015992","name":"St. Luke's Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clon.2020.11.026","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T18:09:05Z","timestamp":1607623745000},"page":"292-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stereotactic Ablative Radiation Therapy for Large (\u22655 cm) Non-small Cell Lung Carcinoma"],"prefix":"10.1016","volume":"33","author":[{"given":"R.L.","family":"McDermott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Keys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"ElBeltagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2020.11.026_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: source, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"Suppl. 4","key":"10.1016\/j.clon.2020.11.026_bib2","doi-asserted-by":"crossref","first-page":"iv68","DOI":"10.1093\/annonc\/mdp132","article-title":"Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"D\u2019Addario","year":"2009","journal-title":"Ann Oncol"},{"issue":"Suppl. 4","key":"10.1016\/j.clon.2020.11.026_bib3","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.clon.2020.11.026_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"issue":"11","key":"10.1016\/j.clon.2020.11.026_bib5","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.clon.2020.11.026_bib6","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2020.11.026_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2009.05.007","article-title":"Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial","volume":"68","author":"Ricardi","year":"2010","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.clon.2020.11.026_bib8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3109\/0284186X.2015.1020966","article-title":"Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience","volume":"54","author":"Lindberg","year":"2015","journal-title":"Acta Oncol"},{"issue":"15","key":"10.1016\/j.clon.2020.11.026_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2020.11.026_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase II study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"10.1016\/j.clon.2020.11.026_bib11","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cncr.30693","article-title":"7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non\u2013small cell lung cancer: results of a phase 2 clinical trial","volume":"123","author":"Sun","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clon.2020.11.026_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JTO.0000000000000169","article-title":"Frequency of lymph node metastasis according to the size of tumors in resected pulmonary adenocarcinoma with a size of 30 mm or smaller","volume":"9","author":"Seok","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.clon.2020.11.026_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","article-title":"The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer","volume":"87","author":"Allibhai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2020.11.026_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clon.2020.11.026_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1017\/S1460396919000037","article-title":"The role of tumour volume as a prognostic factor in non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy","volume":"18","author":"Joyce","year":"2019","journal-title":"J\u00a0Radiother Pract"},{"year":"2019","series-title":"Stereotactic ablative body radiation therapy (SABR): a resource","key":"10.1016\/j.clon.2020.11.026_bib16"},{"issue":"1","key":"10.1016\/j.clon.2020.11.026_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijrobp.2016.09.036","article-title":"Stereotactic body radiation therapy and the influence of chemotherapy on overall survival for large (\u22655 centimeter) non-small cell lung cancer","volume":"97","author":"Verma","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2020.11.026_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.30375","article-title":"Multi-institutional experience of stereotactic body radiotherapy for large (\u22655 centimeters) non-small cell lung tumors","volume":"123","author":"Verma","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clon.2020.11.026_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cllc.2016.11.020","article-title":"Stereotactic body radiotherapy for large (> 5 cm) non-small-cell lung cancer","volume":"18","author":"Peterson","year":"2017","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"10.1016\/j.clon.2020.11.026_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jtho.2017.02.021","article-title":"Use of stereotactic ablative radiotherapy (SABR) in non-small cell lung cancer measuring more than 5 cm","volume":"12","author":"Tekatli","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.clon.2020.11.026_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2015.01.045","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: safety and efficacy","volume":"92","author":"Woody","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2020.11.026_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK consensus on normal tissue dose constraints for stereotactic radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2020.11.026_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijrobp.2017.01.147","article-title":"Stereotactic body radiation therapy for \u22655 cm non-small cell lung cancer: survey of United States academic thoracic radiation oncologists","volume":"98","author":"Post","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"31","key":"10.1016\/j.clon.2020.11.026_bib24","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group study groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2020.11.026_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"15_suppl","key":"10.1016\/j.clon.2020.11.026_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS8580","article-title":"Phase II randomized clinical trial comparing immunotherapy plus stereotactic ablative radiotherapy (I-SABR) versus SABR alone for stage I, selected stage IIa or isolated lung parenchymal recurrent non-small cell lung cancer: I-SABR","volume":"36","author":"Chang","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.11.026_bib27","unstructured":"Durvalumab vs placebo with stereotactic body radiation therapy in early stage unresected non-small cell lung cancer patients (PACIFIC-4). ClinicalTrials.gov NCT03833154."},{"key":"10.1016\/j.clon.2020.11.026_bib28","unstructured":"Efficacy and safety study of stereotactic body radiotherapy (SBRT) with or without pembrolizumab (MK-3475) in adults with medically inoperable stage I or IIA non-small cell lung cancer (NSCLC) (MK-3475-867\/KEYNOTE-867). ClinicalTrials.gov NCT03924869."},{"issue":"3","key":"10.1016\/j.clon.2020.11.026_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2008.07.013","article-title":"Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy","volume":"88","author":"Chen","year":"2008","journal-title":"Radiother Oncol"},{"issue":"13","key":"10.1016\/j.clon.2020.11.026_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2020.11.026_bib31","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z","article-title":"Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group","volume":"59","author":"Perez","year":"1987","journal-title":"Cancer"},{"issue":"9072","key":"10.1016\/j.clon.2020.11.026_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0140-6736(97)06305-8","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee","volume":"350","author":"Saunders","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clon.2020.11.026_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.radonc.2011.02.014","article-title":"Dose escalation for non-small cell lung cancer: analysis and modelling of published literature","volume":"99","author":"Partridge","year":"2011","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.clon.2020.11.026_bib34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/thx.56.8.628","article-title":"Radical radiotherapy for stage I\/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review","volume":"56","author":"Rowell","year":"2001","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.clon.2020.11.026_bib35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2020.11.026_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2017.08.029","article-title":"Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy","volume":"125","author":"Horner-Rieber","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.11.026_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2016.11.002","article-title":"A\u00a0histologic basis for the efficacy of SBRT to the lung","volume":"12","author":"Woody","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clon.2020.11.026_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2018.12.022","article-title":"Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: comparing survival outcomes in adenocarcinoma and squamous cell carcinoma","volume":"128","author":"Abel","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2020.11.026_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lungcan.2018.01.021","article-title":"Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer","volume":"118","author":"Baine","year":"2018","journal-title":"Lung Cancer"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520304404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520304404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:49:02Z","timestamp":1760543342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655520304404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0936655520304404"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2020.11.026","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Ablative Radiation Therapy for Large (\u22655 cm) Non-small Cell Lung Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2020.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}